Research Information Only — Educational content, not medical advice. BPC-157 and TB-500 are research compounds, not FDA-approved. This is not an endorsed protocol. Physician review required before use.
Why This Guide Exists
The famous stack, explained without the fan fiction
"Wolverine Stack" is a nickname, and the nickname does a lot of damage — it promises comic-book healing and skips the biology. The truth is more useful: this pairing is popular because the two peptides genuinely complement each other, and it carries a specific risk that the hype never mentions. This guide gives you both — why it works, how it's run, and who should never touch it.
In one sentenceBPC-157 heals locally and raises the VEGF receptors; TB-500 heals systemically and raises VEGF production — so the stack drives tissue repair and new blood-vessel growth from both the signal side and the sensor side at once.
The Two Compounds
Same goal, opposite reach
Local / Targeted
BPC-157
- Gastric pentadecapeptide (15 aa)
- Works at the injury site — tendon, ligament, gut
- Increases VEGF receptors (VEGFR2)
- Best for localized tendon/ligament and gut repair
- Daily dosing; flexible timing
+
Systemic / Body-Wide
TB-500
- Thymosin β4 fragment
- Works throughout the body — mobilizes repair cells
- Increases VEGF production (the signal itself)
- Best for muscle and whole-body recovery
- Longer half-life; less frequent dosing
Why they're considered synergistic
Angiogenesis — growing new blood vessels into damaged tissue — needs both a signal and the sensors to receive it. TB-500 raises the signal; BPC-157 raises the sensors. Neither maximizes the pathway alone; together they hit it from both ends.
TB-500 → ↑ VEGF (signal) · BPC-157 → ↑ VEGFR2 (receptors) → amplified angiogenesis & repair
Mechanism
How the stack heals
01
Blood supply to damaged tissue
Both compounds drive angiogenesis — more blood vessels means more oxygen, nutrients, and repair cells reaching the injury. This is the shared engine of the stack, and the source of both its benefit and its cancer caution.
02
Cell migration and tissue reorganization
TB-500 sequesters actin to mobilize repair and stem cells toward damage; BPC-157 activates repair pathways locally. The result is coordinated rebuilding rather than a single-point patch.
03
Anti-inflammatory action
Both reduce local and systemic inflammation, which is often what stalls healing — turning a chronically inflamed, non-healing injury back toward an active repair state.
04
Different tissues, covered together
BPC-157 shines on tendon, ligament, and gut; TB-500 on muscle and body-wide soft tissue. The combination covers the tissue types a single compound would leave out.
Protocol
How the stack is run
Educational reference from the platform's locked library — not prescribing guidance. Both are investigational; use warrants physician oversight and a verified source.
BPC-157≈ 250–500 mcg daily
Daily subcutaneous, flexible timing (AM/PM or bedtime), no fasting required. Often dosed near the injury for localized issues.
TB-500≈ 250–500 mcg, consistent schedule
Longer half-life allows less-frequent dosing than BPC-157; PM or rest-day timing is common, no fasting required. (Higher community "loading" protocols exist but sit outside this educational reference range.)
Course length4–8 weeks on, then reassess
Acute injuries: ~4–6 weeks. Both support an active repair process — progressive loading or physical therapy during the course determines how durable the result is. Stopping before ~4 weeks rarely gives lasting benefit.
The syringe detail people get wrongFor immediate use, BPC-157 and TB-500 can be drawn into the same syringe — a genuine convenience unique to this pairing. Understand your response to each compound individually before combining them.
Timeline
What to expect
- Weeks 1–2: pain reduction is usually the first change; GI effects (from BPC-157) can appear within days if gut healing is part of the goal.
- Weeks 3–4: pain-free range of motion begins improving; the point past which most durable responders continue.
- Weeks 5–8: load tolerance returns; modified training or loading can resume. Durability depends on rehab done during the cycle, not the peptides alone.
The Caution That Matters
Angiogenesis cuts both ways
Cancer history — do not useThe stack heals by growing new blood vessels. Tumors also depend on new blood vessels for their supply. In someone with existing or prior cancer, that same mechanism is a theoretical risk. The consistent consensus across clinicians and the research community: anyone with a history of cancer, active cancer, or known predisposition should not use BPC-157 or TB-500.
- No long-term human data. Neither compound has human studies beyond about a year; long-term safety is uncharacterized.
- Both are FDA-unapproved research chemicals. BPC-157 is a Category 2 bulk substance; sourcing is unregulated.
- WADA-banned. Tested athletes must not use either compound.
- TBI history. Caution with BPC-157 specifically — forums consistently warn against use in traumatic brain injury.
- Purity is outcome-determining. Contaminated product is the most common cause of no effect or adverse reaction — third-party certificate of analysis is mandatory.
Common Questions
Wolverine Stack questions answered
Why combine them instead of using one?
Because they cover different ground. BPC-157 is local and best for tendon, ligament, and gut; TB-500 is systemic and best for muscle and whole-body recovery. On the blood-vessel-growth pathway they're complementary — TB-500 raises the VEGF signal, BPC-157 raises its receptors — so together they drive repair more completely than either alone.
Can I really put both in one syringe?
Yes — for immediate use, drawing BPC-157 and TB-500 into the same syringe is standard practice for this stack. That's unusual; many peptides must stay separate. It's part of why the pairing is so popular.
Who absolutely should not use it?
Anyone with a personal history of cancer, active cancer, or elevated cancer risk — the angiogenesis mechanism is a theoretical tumor risk. Also tested athletes (WADA-banned), and caution with traumatic brain injury history. Pregnancy and breastfeeding: avoid.
How long until it works, and does it last?
Pain usually eases in the first 1–2 weeks; functional recovery builds over 4–8 weeks. Durability depends on doing the rehab — progressive loading or physical therapy — during the cycle. These support an active repair process; they don't passively fix tissue while you rest.
About the Author
SD
Dr. Scott DelBoccio, DMD
Founding Author · PeptideReport.ai
Dr. DelBoccio is a clinician with thirty years of practice and a focus on peptide pharmacology and regenerative medicine. PeptideReport.ai is the clinician-authored, education-only reference the peptide space lacked — every guide is an independent synthesis of the primary literature, evidence-graded and corrected in the open. No products are sold on this site.
Full Disclaimer
BPC-157 and TB-500 are not approved by the U.S. Food and Drug Administration for any indication and are research compounds; the "Wolverine Stack" is a community protocol, not a medically endorsed therapy. Information on this page is for educational and scientific purposes only and does not constitute medical advice, diagnosis, or treatment. Both compounds carry a theoretical angiogenesis-related cancer caution and lack long-term human safety data. Any use should be under the supervision of a qualified physician, and individuals with any cancer history should not use these compounds. PeptideReport.ai does not manufacture, sell, or endorse any preparation. Content addresses adults 21 and older. Evidence and regulatory classifications continue to evolve.